DATATRAK Announces October Industry Participation
CLEVELAND, Oct. 1, 2012 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a leader in developing cloud-based, unified eClinical technologies and delivering related services for the clinical trials industry, today announced its participation at several industry events during the month of October.
The Center for Healthcare Innovation's
2012 Globalization of Innovation: China, India, and US Pharma Markets Symposium
Research & Development Panel
Microsoft Corporation, Chicago, IL
October 3, 2012
DATATRAK Board Chairman and CEO, Larry Birch, will moderate a Research & Development panel at this symposium, which focuses on opportunities and challenges facing the pharmaceutical industries in China, India, and the U.S.
6th Annual Clinical Forum 2012
The Hague, Netherlands
October 8-10, 2012
The DIA Clinical Forum brings together industry thought leaders across such disciplines as data management, clinical operations, drug safety and medical communications.
Clinical Data Interchange Standards Consortium (CDISC) International Interchange
October 21-26, 2012
The CDISC International Interchange will focus on their latest initiative Coalition for Accelerating Standards and Therapies (CFAST). The goal of CFAST is to accelerate clinical research and medical product development by facilitating the creation and maintenance of data standards, tools, and methods for conducting research in therapeutic areas important to public health. DATATRAK serves on the CDISC Advisory Board.
9th Latin American Congress of Clinical Research (LACCR)
October 24-26, 2012
DIA's 9th LACCR is the top regional academic forum on clinical research in Latin America, focusing on fostering the integration of professionals in the field.
DATATRAK is the leader of unified eClinical™ technologies and related services for the clinical trials industry. Using the DATATRAK ONE™ multi-product, cloud-based clinical research platform, DATATRAK's Clinical and Consulting Services™ group assists clients in conducting Phase I-IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit www.datatrak.net.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on August 15, 2012 announcing its results for the three-month period ending June 30, 2012. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.